Author/ Treatment | Patient No. | Efficacy Response (%) | PFS (%) | Survival (%) | ||||||||||
CR | PR | SD | 2 years | 3 years | 4 years | 5 years | 2 years | 3 years | 4 years | 5 years | 10 years | 15 years | ||
Packer, et al. 1997 [4] Carboplatin, Vincristine | 78 | 5.1 | 28.2 | 60.2 | 75 | 68 | - | - | - | - | - | - | - | - |
Prados, et al. 1997 [5] Nitrosourea and multiagent chemotherapy | 42 | 0 | 35.7 | 59.5 | - | 45 | - | - | - | - | - | 78 | - | - |
Gururangan, et al. 2002 [6] Carboplatin | 80 | 2 | 17 | 50 | - | 64 | - | - | 84 | - | - | - | - | - |
Burzynski, et al. 2016, Antineoplastons | 16 | 25 | 12.5 | 37.5 | 61.9 | 55.0 | 48.1 | 48.1 | 81.3 | 74.5 | 67.7 | 67.7 | 54.2 | 54.2 |